CNS Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Armistice Capital, LLC(3.20%),Steven Boyd(3.20%)
CNS Pharmaceuticals | 4:持股变动声明-股东 Cortice Biosciences, Inc.
CNS Pharmaceuticals | 3:首次持股声明-股东 Cortice Biosciences, Inc.
CNS Pharmaceuticals | SC 13D:超过5%持股股东披露文件-Cortice Biosciences, Inc.(5.7%)
CNS Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Robert Forster(0%)
CNS Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Robert Forster(0%)
CNS Pharmaceuticals | 4:持股变动声明-董事 Mahery Amy
CNS Pharmaceuticals | 4:持股变动声明-董事 Keyes Jeffry R.
CNS Pharmaceuticals | 4:持股变动声明-董事 Gumulka Jerzy
CNS Pharmaceuticals | 4:持股变动声明-董事 Evans Carl Anthony
CNS Pharmaceuticals | 4:持股变动声明-高管 Downs Christopher
CNS Pharmaceuticals | 4:持股变动声明-董事 Cockroft Bettina M.
CNS Pharmaceuticals | 4:持股变动声明-高管 Climaco John M
CNS Pharmaceuticals | 4:持股变动声明-董事 Charles Faith L.
CNS Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
CNS Pharmaceuticals | 4:持股变动声明-董事 Gumulka Jerzy
CNS Pharmaceuticals | 4:持股变动声明-董事 Mahery Amy
CNS Pharmaceuticals | 4:持股变动声明-董事 Evans Carl Anthony
CNS Pharmaceuticals | 4:持股变动声明-高管 Downs Christopher
CNS Pharmaceuticals | 4:持股变动声明-高管 Climaco John M